Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP1-38 in pegylated phospholipid micelles

Peptides

Volumn 25, Issue 8, 2004, Pages 1253-1258

  Ashok, Beena ^a   Rubinstein, Israel ^a,b   Tsueshita, Takaya ^a   Önyüksel, Hayat ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c University of Illinois at Chicago   (United States)

Author keywords

Arteriole; DSPE PEG; Hamster; Microcirculation; Neuropeptide; Sterically stabilized micelles; Vasomotor tone

Indexed keywords

AMINO ACID; ETHANOLAMINE DERIVATIVE; MACROGOL; NEUROPEPTIDE; PEPTIDE; PHOSPHOLIPID; PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; HAMSTER; IN VIVO STUDY; INCUBATION TIME; MICELLE; MICROCIRCULATION; MICROSCOPY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN INTERACTION; TEMPERATURE; VASODILATATION;

ANIMALS; ARTERIOLES; CRICETINAE; DRUG CARRIERS; MESOCRICETUS; MICELLES; MOLECULAR WEIGHT; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHOLIPIDS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; POLYETHYLENE GLYCOLS; VASOACTIVE INTESTINAL PEPTIDE; VASOCONSTRICTION;

CRICETINAE;

EID: 4444329334     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.05.013     Document Type: Article

References (23)

1. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37:1992;287-303
2. Davis M.J., Joyner W.L., Gilmore J.P. Microvascular pressure distribution and responses of pulmonary allografts and cheek pouch arterioles in the hamster to oxygen. Circ. Res. 49:1981;125-132
3. Delgado M., Abad C., Martinez C., Juarranz M.G., Leceta J., Ganea D., et al. PACAP in immunity and inflammation. Ann. N.Y. Acad. Sci. 992:2003;141-157
4. Gandhi S., Rubinstein I., Tsueshita T., Onyuksel H. Secretin self-assembles and interacts spontaneously with phospholipids in vitro. Peptides. 23:2002;201-204
5. Gao X.P., Noda Y., Rubinstein I., Paul S. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. Life Sci. 54:1994;L247-L252
6. Gololobov G., Noda Y., Sherman S., Rubinstein I., Baranowska-Kortylewicz J., Paul S. Stabilization of vasoactive intestinal peptide by lipids. J. Pharmacol. Exp. Ther. 285:1998;753-758
7. Gozes I., Fridkinb M., Hill J.M., Brenneman D.E. Pharmaceutical VIP: prospects and problems. Curr. Med. Chem. 6:1999;1019-1034
8. Ikezaki H., Paul S., Alkan-Onyuksel H., Patel M., Gao X.P., Rubinstein I. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. Am. J. Physiol. 275:1998;R56-R62
9. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574
10. Onyuksel H., Bodalia B., Sethi V., Dagar S., Rubinstein I. Surface-active properties of vasoactive intestinal peptide. Peptides. 21:2000;419-423
11. Onyuksel H., Ikezaki H., Patel M., Gao X.P., Rubinstein I. A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo. Pharm. Res. 16:1999;155-160
12. Raud J. Intravital microscopic studies on acute mast cell-dependent inflammation. Acta Physiol. Scand. Suppl. 578:1989;1-58
13. Robinson R.M., Blakeney E.W. Jr., Mattice W.L. Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide. Biopolymers. 21:1982;1217-1228
14. Rubinstein I., Mayhan W.G. L-Arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy but not in controls. J. Lab. Clin. Med. 125:1995;313-318
15. Rubinstein I., Patel M., Ikezaki H., Dagar S., Onyuksel H. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin. Peptides. 20:1999;1497-1501
16. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 169:1970;1217-1218
17. Sejourne F., Rubinstein I., Suzuki H., Alkan-Onyuksel H. Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. Pharm. Res. 14:1997;362-365
18. Sejourne F., Suzuki H., Alkan-Onyuksel H., Gao X.P., Ikezaki H., Rubinstein I. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. Am. J. Physiol. 273:1997;R287-R292
19. Suzuki H., Gao X.P., Olopade C.O., Rubinstein I. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ. Am. J. Physiol. 271:1996;R393-R397
20. Suzuki H., Noda Y., Gao X.P., Sejourne F., Alkan-Onyuksel H., Paul S., et al. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Am. J. Physiol. 271:1996;H282-H287
21. Suzuki H., Noda Y., Paul S., Gao X.P., Rubinstein I. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Life Sci. 57:1995;1451-1457
22. Tseushita T., Gandhi S., Onyuksel H., Rubinstein I. Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1-38). J. Appl. Physiol. 93:2002;1377-1383
23. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52:2000;269-324